BPAX Financial Facts
DILUTED NET LOSS PER SHARE (in dollars per share): 0.22WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING (in shares): 11.47M
See Full Income Statement
TOTAL CURRENT LIABILITIES: 30.49M
TOTAL CURRENT ASSETS: 95.48M
See Full Balance Sheet
BioSante Pharmaceuticals, Inc. (BPAX) Earnings
|
Expand Research on BPAX
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -15.9% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +0.3% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/8/12 | Q312 | -$0.27 | -$0.36 | +$0.09 | N/A | $100K | N/A |  | | Details | |
| 11/9/11 | Q311 | -$0.12 | -$0.14 | +$0.02 | $182.78K | $30K | N/A | | | Details | |
| 7/25/11 | Q211 | -$0.16 | -$0.10 | -$0.06 | N/A | N/A | N/A | | | Details | |
| 5/10/11 | Q111 | -$0.20 | -$0.14 | -$0.06 | N/A | $10K | N/A | | | Details |
